Preoperative But Not Postoperative Flurbiprofen Axetil Alleviates Remifentanil-induced Hyperalgesia After Laparoscopic Gynecological Surgery: A Prospective, Randomized, Double-blinded, Trial
Overview
Affiliations
Background: Acute remifentanil exposure during intraoperative analgesia might enhance sensitivity to noxious stimuli and nociceptive responses to innocuous irritation. Cyclooxygenase inhibition was demonstrated to attenuate experimental remifentanil-induced hyperalgesia (RIH) in rodents and human volunteers. The study aimed to compare the effects of preoperative and postoperative flurbiprofen axetil (FA) on RIH after surgery.
Materials And Methods: Ninety patients undergoing elective laparoscopic gynecologic surgery were randomly assigned to receive either intravenous placebo before anesthesia induction (Group C); or intravenous FA (1.0 mg/kg) before anesthesia induction (Group F1) or before skin closure (Group F2). Anesthesia consisted off sevoflurane and remifentanil (0.30 μg/kg/min). Postoperative pain was managed by sufentanil titration in the postanesthetic care unit, followed by sufentanil infusion via patient-controlled analgesia. Mechanical pain threshold (primary outcome), pain scores, sufentanil consumption, and side-effects were documented for 24 hours postoperatively.
Results: Postoperative pain score in Group F1 was lower than Group C. Time of first postoperative sufentanil titration was prolonged in Group F1 than Group C (P=0.021). Cumulative sufentanil consumption in Group F1 was lower than Group C (P<0.001), with a mean difference of 8.75 (95% confidence interval, 5.21-12.29) μg. Mechanical pain threshold on the dominant inner forearm was more elevated in Group F1 than Group C (P=0.005), with a mean difference of 17.7 (95% confidence interval, 5.4-30.0) g. Normalized hyperalgesia area was decreased in Group F1 compared to Group C (P=0.007). No statistically significant difference was observed between Group F2 and Group C.
Conclusions: Preoperative FA reduces postoperative RIH in patients undergoing laparoscopic gynecologic surgery under sevoflurane-remifentanil anesthesia.
Zhao Y, Mu H, Zhang J, Lu Y Exp Ther Med. 2023; 26(4):475.
PMID: 37664672 PMC: 10469147. DOI: 10.3892/etm.2023.12174.
Jia Z, Chen Y, Gao T, Yuan Y, Zheng Y, Xie Y Front Pharmacol. 2023; 14:1131812.
PMID: 36762101 PMC: 9905252. DOI: 10.3389/fphar.2023.1131812.
Zhang L, Jia Z, Gao T, Wang Y, Zhao Y, Li J Front Mol Neurosci. 2023; 16:967917.
PMID: 36760605 PMC: 9905139. DOI: 10.3389/fnmol.2023.967917.
Zhang H, Li N, Li Z, Li Y, Yu Y, Zhang L Front Pharmacol. 2022; 13:898574.
PMID: 35592413 PMC: 9110832. DOI: 10.3389/fphar.2022.898574.
Pre-emptive and preventive NSAIDs for postoperative pain in adults undergoing all types of surgery.
Doleman B, Leonardi-Bee J, Heinink T, Boyd-Carson H, Carrick L, Mandalia R Cochrane Database Syst Rev. 2021; 6:CD012978.
PMID: 34125958 PMC: 8203105. DOI: 10.1002/14651858.CD012978.pub2.